{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:42:03Z","timestamp":1789004523525,"version":"build-2803163510"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00415-026-13970-3","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:20:36Z","timestamp":1782976836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3510-7573","authenticated-orcid":false,"given":"Floor","family":"Koks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Reubens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hymke","family":"van der Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1405-5232","authenticated-orcid":false,"given":"Jacco Jan","family":"Bried\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"13970_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/WCO.0000000000000094","volume":"27","author":"R Dutta","year":"2014","unstructured":"Dutta R, Trapp BD (2014) Relapsing and progressive forms of multiple sclerosis: insights from pathology. Curr Opin Neurol 27:271\u2013278. https:\/\/doi.org\/10.1097\/WCO.0000000000000094","journal-title":"Curr Opin Neurol"},{"key":"13970_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41582-022-00624-x","volume":"18","author":"LM Healy","year":"2022","unstructured":"Healy LM, Stratton JA, Kuhlmann T, Antel J (2022) The role of glial cells in multiple sclerosis disease progression. Nat Rev Neurol 18:237\u2013248. https:\/\/doi.org\/10.1038\/s41582-022-00624-x","journal-title":"Nat Rev Neurol"},{"key":"13970_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102194","volume":"63","author":"M Gharagozloo","year":"2022","unstructured":"Gharagozloo M, Bannon R, Calabresi PA (2022) Breaking the barriers to remyelination in multiple sclerosis. Curr Opin Pharmacol 63:102194. https:\/\/doi.org\/10.1016\/j.coph.2022.102194","journal-title":"Curr Opin Pharmacol"},{"key":"13970_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WCO.0000000000000206","volume":"28","author":"I Katz Sand","year":"2015","unstructured":"Katz Sand I (2015) Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol 28:193\u2013205. https:\/\/doi.org\/10.1097\/WCO.0000000000000206","journal-title":"Curr Opin Neurol"},{"key":"13970_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintor\u00e9 M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"13970_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2217\/nmt-2021-0058","volume":"13","author":"M Amin","year":"2023","unstructured":"Amin M, Hersh CM (2023) Updates and advances in multiple sclerosis neurotherapeutics, Neurodegener. Dis Manag 13:47\u201370. https:\/\/doi.org\/10.2217\/nmt-2021-0058","journal-title":"Dis Manag"},{"key":"13970_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrd.2017.115","volume":"16","author":"JR Plemel","year":"2017","unstructured":"Plemel JR, Liu W-Q, Yong VW (2017) Remyelination therapies: a new direction and challenge in multiple sclerosis. Nat Rev Drug Discov 16:617\u2013634. https:\/\/doi.org\/10.1038\/nrd.2017.115","journal-title":"Nat Rev Drug Discov"},{"key":"13970_CR8","doi-asserted-by":"publisher","DOI":"10.31083\/JIN25081","volume":"24","author":"S Lorenzut","year":"2025","unstructured":"Lorenzut S, Negro ID, Pauletto G, Verriello L, Spadea L, Salati C, Musa M, Gagliano C, Zeppieri M (2025) Exploring the pathophysiology, diagnosis, and treatment options of multiple sclerosis. J Integr Neurosci 24:e25081. https:\/\/doi.org\/10.31083\/JIN25081","journal-title":"J Integr Neurosci"},{"key":"13970_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037297","volume":"103","author":"M Haki","year":"2024","unstructured":"Haki M, Al-Biati HA, Al-Tameemi ZS, Ali IS, Al-Hussaniy HA (2024) Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment. Medicine (Baltimore) 103:e37297. https:\/\/doi.org\/10.1097\/MD.0000000000037297","journal-title":"Medicine (Baltimore)"},{"key":"13970_CR10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/biom12060802","volume":"12","author":"M Yang","year":"2022","unstructured":"Yang M, Lu Y, Piao W, Jin H (2022) The Translational Regulation in mTOR Pathway. Biomolecules 12:802. https:\/\/doi.org\/10.3390\/biom12060802","journal-title":"Biomolecules"},{"key":"13970_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158077","author":"AG Vakrakou","year":"2022","unstructured":"Vakrakou AG, Alexaki A, Brinia M-E, Anagnostouli M, Stefanis L, Stathopoulos P (2022) The mTOR signaling pathway in multiple sclerosis; from animal models to human data. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23158077","journal-title":"Int J Mol Sci"},{"key":"13970_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/B978-0-12-802733-2.00004-9","volume-title":"Molecules to Medicine with mTOR","author":"CD Russo","year":"2016","unstructured":"Russo CD, Navarra P, Lisi L (2016) mTOR in Multiple Sclerosis. In: Maiese K (ed) Molecules to Medicine with mTOR. Elsevier, pp 331\u2013343"},{"key":"13970_CR13","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122:3589\u20133594. https:\/\/doi.org\/10.1242\/jcs.051011","journal-title":"J Cell Sci"},{"key":"13970_CR14","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3892\/etm.2017.4410","volume":"13","author":"W-J Huang","year":"2017","unstructured":"Huang W-J, Chen W-W, Zhang X (2017) Multiple sclerosis: Pathology, diagnosis and treatments. Exp Ther Med 13:3163\u20133166. https:\/\/doi.org\/10.3892\/etm.2017.4410","journal-title":"Exp Ther Med"},{"key":"13970_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00109-023-02312-9","volume":"101","author":"M Devanand","year":"2023","unstructured":"Devanand M, Madhu SNVK (2023) Signaling mechanisms involved in the regulation of remyelination in multiple sclerosis: a mini review. J Mol Med 101:637\u2013644. https:\/\/doi.org\/10.1007\/s00109-023-02312-9","journal-title":"J Mol Med"},{"key":"13970_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000484629","volume":"64","author":"T Weichhart","year":"2018","unstructured":"Weichhart T (2018) MTOR as regulator of lifespan, aging, and cellular senescence: A mini-review. Gerontology 64:127\u2013134. https:\/\/doi.org\/10.1159\/000484629","journal-title":"Gerontology"},{"key":"13970_CR17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.prosdent.2022.05.019","volume":"131","author":"VH Sheth","year":"2024","unstructured":"Sheth VH, Shah NP, Jain R, Bhanushali N, Bhatnagar V (2024) Development and validation of a risk-of-bias tool for assessing in vitro studies conducted in dentistry: the QUIN. J Prosthet Dent 131:1038\u20131042. https:\/\/doi.org\/10.1016\/j.prosdent.2022.05.019","journal-title":"J Prosthet Dent"},{"key":"13970_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43. https:\/\/doi.org\/10.1186\/1471-2288-14-43","journal-title":"BMC Med Res Methodol"},{"key":"13970_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1524-475X.2004.04006.x","volume":"1","author":"BH Thomas","year":"2004","unstructured":"Thomas BH, Ciliska D, Dobbins M, Micucci S (2004) A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 1:176\u2013184. https:\/\/doi.org\/10.1111\/j.1524-475X.2004.04006.x","journal-title":"Worldviews Evid Based Nurs"},{"key":"13970_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbrc.2021.08.010","volume":"573","author":"M He","year":"2021","unstructured":"He M, Wu D-M, Zhao Y-Y, Yu Y, Deng S-H, Liu T, Zhang T, Li J, Wang F, Xu Y (2021) AZD8055 ameliorates experimental autoimmune encephalomyelitis via the mTOR\/ROS\/NLRP3 pathway. Biochem Biophys Res Commun 573:27\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.010","journal-title":"Biochem Biophys Res Commun"},{"key":"13970_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10753-018-0887-3","volume":"42","author":"N Rezaei","year":"2019","unstructured":"Rezaei N, Talebi F, Ghorbani S, Rezaei A, Esmaeili A, Noorbakhsh F, Hakemi MG (2019) MicroRNA-92a drives Th1 responses in the experimental autoimmune encephalomyelitis. Inflammation 42:235\u2013245. https:\/\/doi.org\/10.1007\/s10753-018-0887-3","journal-title":"Inflammation"},{"key":"13970_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri798","volume":"2","author":"RN Germain","year":"2002","unstructured":"Germain RN (2002) T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol 2:309\u2013322. https:\/\/doi.org\/10.1038\/nri798","journal-title":"Nat Rev Immunol"},{"key":"13970_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s11481-015-9614-0","volume":"10","author":"L Legroux","year":"2015","unstructured":"Legroux L, Arbour N (2015) Multiple sclerosis and T lymphocytes: An entangled story. J Neuroimmune Pharmacol 10:528\u2013546. https:\/\/doi.org\/10.1007\/s11481-015-9614-0","journal-title":"J Neuroimmune Pharmacol"},{"key":"13970_CR24","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.4049\/jimmunol.1601139","volume":"198","author":"L Negrotto","year":"2017","unstructured":"Negrotto L, Correale J (2017) Amino acid catabolism in multiple sclerosis affects immune homeostasis. J Immunol 198:1900\u20131909. https:\/\/doi.org\/10.4049\/jimmunol.1601139","journal-title":"J Immunol"},{"key":"13970_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.neuroscience.2019.01.038","volume":"406","author":"H Yamate-Morgan","year":"2019","unstructured":"Yamate-Morgan H, Lauderdale K, Horeczko J, Merchant U, Tiwari-Woodruff SK (2019) Functional effects of cuprizone-induced demyelination in the presence of the mTOR-inhibitor rapamycin. Neuroscience 406:667\u2013683. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.01.038","journal-title":"Neuroscience"},{"key":"13970_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","volume":"116","author":"S Giacoppo","year":"2017","unstructured":"Giacoppo S, Pollastro F, Grassi G, Bramanti P, Mazzon E (2017) Target regulation of PI3K\/Akt\/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis. Fitoterapia 116:77\u201384. https:\/\/doi.org\/10.1016\/j.fitote.2016.11.010","journal-title":"Fitoterapia"},{"key":"13970_CR27","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.3390\/ijms20184323","volume":"20","author":"SD Lombardo","year":"2019","unstructured":"Lombardo SD, Mazzon E, Basile MS, Campo G, Corsico F, Presti M, Bramanti P, Mangano K, Petralia MC, Nicoletti F, Fagone P (2019) Modulation of tetraspanin 32 (TSPAN32) expression in T cell-mediated immune responses and in multiple sclerosis. Int J Mol Sci 20:4323. https:\/\/doi.org\/10.3390\/ijms20184323","journal-title":"Int J Mol Sci"},{"key":"13970_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molimm.2023.05.005","volume":"159","author":"M Sun","year":"2023","unstructured":"Sun M, Gong P, Yuan B, Liu N, Li X, Zhang W, Wang M (2023) AXL-Induced Autophagy mitigates experimental autoimmune encephalomyelitis by suppressing microglial inflammation via the PI3K\/AKT\/mTOR signaling pathway. Mol Immunol 159:15\u201327. https:\/\/doi.org\/10.1016\/j.molimm.2023.05.005","journal-title":"Mol Immunol"},{"key":"13970_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf1230","author":"IC Clark","year":"2021","unstructured":"Clark IC, Guti\u00e9rrez-V\u00e1zquez C, Wheeler MA, Li Z, Rothhammer V, Linnerbauer M, Sanmarco LM, Guo L, Blain M, Zandee SEJ, Chao C-C, Batterman KV, Schwabenland M, Lotfy P, Tejeda-Velarde A, Hewson P, Manganeli Polonio C, Shultis MW, Salem Y, Tjon EC, Fonseca-Castro PH, Borucki DM, Alves de Lima K, Plasencia A, Abate AR, Rosene DL, Hodgetts KJ, Prinz M, Antel JP, Prat A, Quintana FJ (2021) Barcoded viral tracing of single-cell interactions in central nervous system inflammation. Science. https:\/\/doi.org\/10.1126\/science.abf1230","journal-title":"Science"},{"key":"13970_CR30","doi-asserted-by":"publisher","first-page":"1075161","DOI":"10.3389\/fnagi.2022.1075161","volume":"14","author":"W Sun","year":"2022","unstructured":"Sun W, Wen M, Liu M, Wang Q, Liu Q, Li L, Siebert H-C, Loers G, Zhang R, Zhang N (2022) Effect of \u03b2-hydroxybutyrate on behavioral alterations, molecular and morphological changes in CNS of multiple sclerosis mouse model. Front Aging Neurosci 14:1075161. https:\/\/doi.org\/10.3389\/fnagi.2022.1075161","journal-title":"Front Aging Neurosci"},{"key":"13970_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167457","author":"P Baeten","year":"2024","unstructured":"Baeten P, Hamad I, Hoeks C, Hiltensperger M, Van Wijmeersch B, Popescu V, Aly L, Somers V, Korn T, Kleinewietfeld M, Hellings N, Broux B (2024) Rapamycin rescues loss of function in blood-brain barrier-interacting Tregs. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.167457","journal-title":"JCI Insight."},{"key":"13970_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.immuni.2020.03.013","volume":"52","author":"D DiToro","year":"2020","unstructured":"DiToro D, Harbour SN, Bando JK, Benavides G, Witte S, Laufer VA, Moseley C, Singer JR, Frey B, Turner H, Bruning J, Darley-Usmar V, Gao M, Conover C, Hatton RD, Frank S, Colonna M, Weaver CT (2020) Insulin-like growth factors are key regulators of T helper 17 regulatory T cell balance in autoimmunity. Immunity 52:650-667.e10. https:\/\/doi.org\/10.1016\/j.immuni.2020.03.013","journal-title":"Immunity"},{"key":"13970_CR33","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s11064-017-2296-7","volume":"42","author":"H Hou","year":"2017","unstructured":"Hou H, Miao J, Cao R, Han M, Sun Y, Liu X, Guo L (2017) Rapamycin ameliorates experimental autoimmune encephalomyelitis by suppressing the mTOR-STAT3 pathway. Neurochem Res 42:2831\u20132840. https:\/\/doi.org\/10.1007\/s11064-017-2296-7","journal-title":"Neurochem Res"},{"key":"13970_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/cells12030450","volume":"12","author":"L Meyer-Heemsoth","year":"2023","unstructured":"Meyer-Heemsoth L, Mitschke K, Bier J, Sch\u00fctz K, Villunger A, Legler TJ, Weber MS, L\u00fchder F, Reichardt HM (2023) T cell energy metabolism is a target of glucocorticoids in mice, healthy humans, and MS patients. Cells 12:450. https:\/\/doi.org\/10.3390\/cells12030450","journal-title":"Cells"},{"key":"13970_CR35","doi-asserted-by":"publisher","first-page":"1184938","DOI":"10.3389\/fbioe.2023.1184938","volume":"11","author":"CJ Bridgeman","year":"2023","unstructured":"Bridgeman CJ, Shah SA, Oakes RS, Jewell CM (2023) Dissecting regulatory T cell expansion using polymer microparticles presenting defined ratios of self-antigen and regulatory cues. Front Bioeng Biotechnol 11:1184938. https:\/\/doi.org\/10.3389\/fbioe.2023.1184938","journal-title":"Front Bioeng Biotechnol"},{"key":"13970_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.18502\/ijaai.v19i2.2771","volume":"19","author":"S Rezapour-Firouzi","year":"2020","unstructured":"Rezapour-Firouzi S, Mohammadian M, Sadeghzadeh M, Mehranfar S, Mazloomi E (2020) The effects of evening primrose\/hemp seed oil compared to rapamycin on the gene expression of immunological parameters in experimental autoimmune encephalomyelitis splenocytes. Iran J Allergy Asthma Immunol 19:183\u2013192. https:\/\/doi.org\/10.18502\/ijaai.v19i2.2771","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"13970_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2019.04.035","volume":"705","author":"Z Li","year":"2019","unstructured":"Li Z, Nie L, Chen L, Sun Y, Li G (2019) Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg\/Th17 in a mouse model. Neurosci Lett 705:39\u201345. https:\/\/doi.org\/10.1016\/j.neulet.2019.04.035","journal-title":"Neurosci Lett"},{"key":"13970_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/jir.2021.0206","volume":"42","author":"PA Borim","year":"2022","unstructured":"Borim PA, Mimura LAN, Zorzella-Pezavento SFG, Polonio CM, Peron JPS, Sartori A, de Fraga-Silva TFC (2022) Effect of rapamycin on MOG-reactive immune cells and lipopolysaccharide-activated microglia: An in vitro approach for screening new therapies for multiple sclerosis. J Interferon Cytokine Res 42:153\u2013160. https:\/\/doi.org\/10.1089\/jir.2021.0206","journal-title":"J Interferon Cytokine Res"},{"key":"13970_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.590884","volume":"11","author":"X-L Li","year":"2020","unstructured":"Li X-L, Zhang B, Liu W, Sun M-J, Zhang Y-L, Liu H, Wang M-X (2020) Rapamycin alleviates the symptoms of multiple sclerosis in experimental autoimmune encephalomyelitis (EAE) through mediating the TAM-TLRs-SOCS pathway. Front Neurol 11:590884. https:\/\/doi.org\/10.3389\/fneur.2020.590884","journal-title":"Front Neurol"},{"key":"13970_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577067","volume":"337","author":"Y Boyao","year":"2019","unstructured":"Boyao Y, Mengjiao S, Caicai B, Xiaoling L, Zhenxing L, Manxia W (2019) Dynamic expression of autophagy-related factors in autoimmune encephalomyelitis and exploration of curcumin therapy. J Neuroimmunol 337:577067. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577067","journal-title":"J Neuroimmunol"},{"key":"13970_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12974-024-03165-w","volume":"21","author":"K Leng","year":"2024","unstructured":"Leng K, Rooney B, McCarthy F, Xia W, Rose IVL, Bax S, Chin M, Fathi S, Herrington KA, Leonetti M, Kao A, Fancy SPJ, Elias JE, Kampmann M (2024) mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes. J Neuroinflammation 21:198. https:\/\/doi.org\/10.1186\/s12974-024-03165-w","journal-title":"J Neuroinflammation"},{"key":"13970_CR42","doi-asserted-by":"publisher","first-page":"22398","DOI":"10.1038\/s41598-024-73259-1","volume":"14","author":"N-E Neili","year":"2024","unstructured":"Neili N-E, AbdelKafi-Koubaa Z, Jebali J, Kaidi K, Sahraoui G, Ahmed MB, Srairi-Abid N, Marrakchi N, Doghri R, Elbini I (2024) Modulation of \u03b1v integrins by lebecetin, a viper venom-derived molecule, in experimental neuroinflammation and demyelination models. Sci Rep 14:22398. https:\/\/doi.org\/10.1038\/s41598-024-73259-1","journal-title":"Sci Rep"},{"key":"13970_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.intimp.2015.11.024","volume":"30","author":"H Hou","year":"2016","unstructured":"Hou H, Cao R, Miao J, Sun Y, Liu X, Song X, Guo L (2016) Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice. Int Immunopharmacol 30:171\u2013178. https:\/\/doi.org\/10.1016\/j.intimp.2015.11.024","journal-title":"Int Immunopharmacol"},{"key":"13970_CR44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2020078118","volume":"118","author":"S Patergnani","year":"2021","unstructured":"Patergnani S, Bonora M, Ingusci S, Previati M, Marchi S, Zucchini S, Perrone M, Wieckowski MR, Castellazzi M, Pugliatti M, Giorgi C, Simonato M, Pinton P (2021) Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis. Proc Natl Acad Sci U S A 118:e2020078118. https:\/\/doi.org\/10.1073\/pnas.2020078118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13970_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02099-y","author":"N Wu","year":"2024","unstructured":"Wu N, Zhao Y, Xiao M, Liu H, Chen H, Liu B, Wang X, Fan X (2024) Methylprednisolone modulates the Tfr\/Tfh ratio in EAE-induced neuroinflammation through the PI3K\/AKT\/FoxO1 and PI3K\/AKT\/mTOR signalling pathways. Inflammation. https:\/\/doi.org\/10.1007\/s10753-024-02099-y","journal-title":"Inflammation"},{"key":"13970_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/cells7090119","volume":"7","author":"M Gharagozloo","year":"2018","unstructured":"Gharagozloo M, Mahmoud S, Simard C, Mahvelati TM, Amrani A, Gris D (2018) The dual immunoregulatory function of Nlrp12 in T cell-mediated immune response: Lessons from Experimental Autoimmune Encephalomyelitis. Cells 7:119. https:\/\/doi.org\/10.3390\/cells7090119","journal-title":"Cells"},{"key":"13970_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578200","volume":"384","author":"S Chhabra","year":"2023","unstructured":"Chhabra S, Mehan S, Khan Z, Gupta GD, Narula AS (2023) Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations. J Neuroimmunol 384:578200. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578200","journal-title":"J Neuroimmunol"},{"key":"13970_CR48","doi-asserted-by":"publisher","first-page":"9628","DOI":"10.1021\/acs.jmedchem.4c00788","volume":"67","author":"M Yu","year":"2024","unstructured":"Yu M, Wang X, Tang Y, Wang L, Hu X, Weng Q, Wang J, Cui S (2024) Discovery of novel azaindoles as potent and selective PI3K\u03b4 inhibitors for treatment of multiple sclerosis. J Med Chem 67:9628\u20139644. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00788","journal-title":"J Med Chem"},{"key":"13970_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117747","volume":"253","author":"L Xu","year":"2020","unstructured":"Xu L, Zhang C, He D, Jiang N, Bai Y, Xin Y (2020) Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis. Life Sci 253:117747. https:\/\/doi.org\/10.1016\/j.lfs.2020.117747","journal-title":"Life Sci"},{"key":"13970_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.molimm.2017.11.002","volume":"93","author":"Q Zhao","year":"2018","unstructured":"Zhao Q, Cheng W, Xi Y, Cao Z, Xu Y, Wu T, Li C, Niu X, Chen G (2018) IFN-\u03b2 regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis. Mol Immunol 93:20\u201330. https:\/\/doi.org\/10.1016\/j.molimm.2017.11.002","journal-title":"Mol Immunol"},{"key":"13970_CR51","doi-asserted-by":"publisher","first-page":"18061","DOI":"10.1073\/pnas.1411294111","volume":"111","author":"SM Moore","year":"2014","unstructured":"Moore SM, Khalaj AJ, Kumar S, Winchester Z, Yoon J, Yoo T, Martinez-Torres L, Yasui N, Katzenellenbogen JA, Tiwari-Woodruff SK (2014) Multiple functional therapeutic effects of the estrogen receptor \u03b2 agonist indazole-Cl in a mouse model of multiple sclerosis. Proc Natl Acad Sci U S A 111:18061\u201318066. https:\/\/doi.org\/10.1073\/pnas.1411294111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13970_CR52","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.7150\/thno.87130","volume":"14","author":"Y Wei","year":"2024","unstructured":"Wei Y, Li W, Huang J, Braunstein Z, Liu X, Li X, Deiuliis J, Chen J, Min X, Yang H, Gong Q, He L, Liu Z, Dong L, Zhong J (2024) Midline-1 regulates effector T cell motility in experimental autoimmune encephalomyelitis via mTOR\/microtubule pathway. Theranostics 14:1168\u20131180. https:\/\/doi.org\/10.7150\/thno.87130","journal-title":"Theranostics"},{"key":"13970_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577583","volume":"356","author":"H Hou","year":"2021","unstructured":"Hou H, Sun Y, Miao J, Gao M, Guo L, Song X (2021) Ponesimod modulates the Th1\/Th17\/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis. J Neuroimmunol 356:577583. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577583","journal-title":"J Neuroimmunol"},{"key":"13970_CR54","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41467-019-08711-2","volume":"10","author":"M Luu","year":"2019","unstructured":"Luu M, Pautz S, Kohl V, Singh R, Romero R, Lucas S, Hofmann J, Raifer H, Vachharajani N, Carrascosa LC, Lamp B, Nist A, Stiewe T, Shaul Y, Adhikary T, Zaiss MM, Lauth M, Steinhoff U, Visekruna A (2019) The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat Commun 10:760. https:\/\/doi.org\/10.1038\/s41467-019-08711-2","journal-title":"Nat Commun"},{"key":"13970_CR55","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1096\/fj.201700524R","volume":"31","author":"S Giacoppo","year":"2017","unstructured":"Giacoppo S, Thangavelu SR, Diomede F, Bramanti P, Conti P, Trubiani O, Mazzon E (2017) Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37. FASEB J 31:5592\u20135608. https:\/\/doi.org\/10.1096\/fj.201700524R","journal-title":"FASEB J"},{"key":"13970_CR56","doi-asserted-by":"publisher","first-page":"E1678","DOI":"10.1073\/pnas.1615783114","volume":"114","author":"M Zeitelhofer","year":"2017","unstructured":"Zeitelhofer M, Adzemovic MZ, Gomez-Cabrero D, Bergman P, Hochmeister S, N\u2019diaye M, Paulson A, Ruhrmann S, Almgren M, Tegn\u00e9r JN, Ekstr\u00f6m TJ, Guerreiro-Cacais AO, Jagodic M (2017) Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis \u202c. Proc Natl Acad Sci USA 114:E1678\u2013E1687. https:\/\/doi.org\/10.1073\/pnas.1615783114","journal-title":"Proc Natl Acad Sci USA"},{"key":"13970_CR57","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI73411","volume":"124","author":"T Koga","year":"2014","unstructured":"Koga T, Hedrich CM, Mizui M, Yoshida N, Otomo K, Lieberman LA, Rauen T, Crisp\u00edn JC, Tsokos GC (2014) CaMK4-dependent activation of AKT\/mTOR and CREM-\u03b1 underlies autoimmunity-associated Th17 imbalance. J Clin Invest 124:2234\u20132245. https:\/\/doi.org\/10.1172\/JCI73411","journal-title":"J Clin Invest"},{"key":"13970_CR58","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240625","author":"DS Prado","year":"2025","unstructured":"Prado DS, Cattley RT, Sonego AB, Sutariya P, Wu S, Lee M, Boggess WC, Shlomchik MJ, Hawse WF (2025) The phospholipid kinase PIKFYVE is essential for Th17 differentiation. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20240625","journal-title":"J Exp Med"},{"key":"13970_CR59","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.4049\/jimmunol.1700157","volume":"199","author":"T Hosokawa","year":"2017","unstructured":"Hosokawa T, Kimura T, Nada S, Okuno T, Ito D, Kang S, Nojima S, Yamashita K, Nakatani T, Hayama Y, Kato Y, Kinehara Y, Nishide M, Mikami N, Koyama S, Takamatsu H, Okuzaki D, Ohkura N, Sakaguchi S, Okada M, Kumanogoh A (2017) Lamtor1 is critically required for CD4+ T cell proliferation and regulatory T cell suppressive function. J Immunol 199:2008\u20132019. https:\/\/doi.org\/10.4049\/jimmunol.1700157","journal-title":"J Immunol"},{"key":"13970_CR60","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneuroim.2018.08.012","volume":"324","author":"H Hou","year":"2018","unstructured":"Hou H, Cao R, Quan M, Sun Y, Sun H, Zhang J, Li B, Guo L, Song X (2018) Rapamycin and fingolimod modulate Treg\/Th17 cells in experimental autoimmune encephalomyelitis by regulating the Akt-mTOR and MAPK\/ERK pathways. J Neuroimmunol 324:26\u201334. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.08.012","journal-title":"J Neuroimmunol"},{"key":"13970_CR61","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2016.01.014","volume":"292","author":"Y Sun","year":"2016","unstructured":"Sun Y, Tian T, Gao J, Liu X, Hou H, Cao R, Li B, Quan M, Guo L (2016) Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice. J Neuroimmunol 292:58\u201367. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.01.014","journal-title":"J Neuroimmunol"},{"key":"13970_CR62","doi-asserted-by":"publisher","first-page":"12446","DOI":"10.1074\/jbc.M114.550723","volume":"289","author":"S-Q Liu","year":"2014","unstructured":"Liu S-Q, Jiang S, Li C, Zhang B, Li Q-J (2014) miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation. J Biol Chem 289:12446\u201312456. https:\/\/doi.org\/10.1074\/jbc.M114.550723","journal-title":"J Biol Chem"},{"key":"13970_CR63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lfs.2017.05.010","volume":"180","author":"S-Q Liu","year":"2017","unstructured":"Liu S-Q, Zhang M-L, Zhang H-J, Liu F-Z, Chu R-J, Zhang G-X, Zhu L (2017) Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K\/Akt signaling pathway. Life Sci 180:36\u201341. https:\/\/doi.org\/10.1016\/j.lfs.2017.05.010","journal-title":"Life Sci"},{"key":"13970_CR64","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4103\/1735-5362.245964","volume":"13","author":"S Rezapour-Firouzi","year":"2018","unstructured":"Rezapour-Firouzi S, Shahabi S, Mohammadzadeh A, Tehrani AA, Kheradmand F, Mazloomi E (2018) The potential effects of hemp seed\/evening primrose oils on the mammalian target of rapamycin complex 1 and interferon-gamma genes expression in experimental autoimmune encephalomyelitis. Res Pharm Sci 13:523\u2013532. https:\/\/doi.org\/10.4103\/1735-5362.245964","journal-title":"Res Pharm Sci"},{"key":"13970_CR65","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12264-018-0322-7","volume":"35","author":"F Lu","year":"2019","unstructured":"Lu F, Yin D, Pu Y, Liu W, Li Z, Shao Q, He C, Cao L (2019) Shikimic acid promotes oligodendrocyte precursor cell differentiation and accelerates remyelination in mice. Neurosci Bull 35:434\u2013446. https:\/\/doi.org\/10.1007\/s12264-018-0322-7","journal-title":"Neurosci Bull"},{"key":"13970_CR66","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s12264-021-00696-7","volume":"37","author":"Q Shao","year":"2021","unstructured":"Shao Q, Zhao M, Pei W, Pu Y, Liu M, Liu W, Yu Z, Chen K, Liu H, Deng B, Cao L (2021) Pinocembrin promotes OPC differentiation and remyelination via the mTOR signaling pathway. Neurosci Bull 37:1314\u20131324. https:\/\/doi.org\/10.1007\/s12264-021-00696-7","journal-title":"Neurosci Bull"},{"key":"13970_CR67","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1021\/acs.jafc.0c04604","volume":"68","author":"C Liu","year":"2020","unstructured":"Liu C, Zhang N, Zhang R, Jin L, Petridis AK, Loers G, Zheng X, Wang Z, Siebert H-C (2020) Cuprizone-induced demyelination in mouse hippocampus is alleviated by ketogenic diet. J Agric Food Chem 68:11215\u201311228. https:\/\/doi.org\/10.1021\/acs.jafc.0c04604","journal-title":"J Agric Food Chem"},{"key":"13970_CR68","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41467-023-44556-6","volume":"15","author":"R Berglund","year":"2024","unstructured":"Berglund R, Cheng Y, Piket E, Adzemovic MZ, Zeitelhofer M, Olsson T, Guerreiro-Cacais AO, Jagodic M (2024) The aging mouse CNS is protected by an autophagy-dependent microglia population promoted by IL-34. Nat Commun 15:383. https:\/\/doi.org\/10.1038\/s41467-023-44556-6","journal-title":"Nat Commun"},{"key":"13970_CR69","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1002\/jcb.27792","volume":"120","author":"L Xu","year":"2019","unstructured":"Xu L, Zhang C, Jiang N, He D, Bai Y, Xin Y (2019) Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis. J Cell Biochem 120:5160\u20135168. https:\/\/doi.org\/10.1002\/jcb.27792","journal-title":"J Cell Biochem"},{"key":"13970_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103499","volume":"58","author":"R Masvekar","year":"2022","unstructured":"Masvekar R, Kosa P, Barbour C, Milstein JL, Bielekova B (2022) Drug library screen identifies inhibitors of toxic astrogliosis. Mult Scler Relat Disord 58:103499. https:\/\/doi.org\/10.1016\/j.msard.2022.103499","journal-title":"Mult Scler Relat Disord"},{"key":"13970_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144987","volume":"759","author":"S Rezapour-Firouzi","year":"2020","unstructured":"Rezapour-Firouzi S, Mohammadian M, Sadeghzadeh M, Mazloomi E (2020) Effects of co-administration of rapamycin and evening primrose\/hemp seed oil supplement on immunologic factors and cell membrane fatty acids in experimental autoimmune encephalomyelitis. Gene 759:144987. https:\/\/doi.org\/10.1016\/j.gene.2020.144987","journal-title":"Gene"},{"key":"13970_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671511","volume":"12","author":"E Duarte-Silva","year":"2021","unstructured":"Duarte-Silva E, da Rocha Ara\u00fajo SM, Oliveira WH, L\u00f3s DB, Bonfanti AP, Peron G, de Lima Thomaz L, Verinaud L, Peixoto CA (2021) Sildenafil alleviates murine experimental autoimmune encephalomyelitis by triggering autophagy in the spinal cord. Front Immunol 12:671511. https:\/\/doi.org\/10.3389\/fimmu.2021.671511","journal-title":"Front Immunol"},{"key":"13970_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13731-z","author":"C L\u00fcckel","year":"2019","unstructured":"L\u00fcckel C, Picard F, Raifer H, Campos Carrascosa L, Guralnik A, Zhang Y, Klein M, Bittner S, Steffen F, Moos S, Marini F, Gloury R, Kurschus FC, Chao Y-Y, Bertrams W, Sexl V, Schmeck B, Bonetti L, Grusdat M, Lohoff M, Zielinski CE, Zipp F, Kallies A, Brenner D, Berger M, Bopp T, Tackenberg B, Huber M (2019) IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-13731-z","journal-title":"Nat Commun"},{"key":"13970_CR74","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.4049\/jimmunol.1601912","volume":"198","author":"SA Gibson","year":"2017","unstructured":"Gibson SA, Yang W, Yan Z, Liu Y, Rowse AL, Weinmann AS, Qin H, Benveniste EN (2017) Protein kinase CK2 controls the fate between Th17 cell and regulatory T cell differentiation. J Immunol 198:4244\u20134254. https:\/\/doi.org\/10.4049\/jimmunol.1601912","journal-title":"J Immunol"},{"key":"13970_CR75","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.omtn.2021.07.010","volume":"26","author":"Y Gu","year":"2021","unstructured":"Gu Y, Zhou H, Yu H, Yang W, Wang B, Qian F, Cheng Y, He S, Zhao X, Zhu L, Zhang Y, Jin M, Lu E (2021) miR-99a regulates CD4+ T cell differentiation and attenuates experimental autoimmune encephalomyelitis by mTOR-mediated glycolysis. Mol Ther Nucleic Acids 26:1173\u20131185. https:\/\/doi.org\/10.1016\/j.omtn.2021.07.010","journal-title":"Mol Ther Nucleic Acids"},{"key":"13970_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00251-015-0881-y","volume":"68","author":"M Ahmadian-Elmi","year":"2016","unstructured":"Ahmadian-Elmi M, Bidmeshki Pour A, Naghavian R, Ghaedi K, Tanhaei S, Izadi T, Nasr-Esfahani MH (2016) miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis. Immunogenetics 68:43\u201354. https:\/\/doi.org\/10.1007\/s00251-015-0881-y","journal-title":"Immunogenetics"},{"key":"13970_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124555","volume":"10","author":"R Naghavian","year":"2015","unstructured":"Naghavian R, Ghaedi K, Kiani-Esfahani A, Ganjalikhani-Hakemi M, Etemadifar M, Nasr-Esfahani MH (2015) MiR-141 and miR-200a, revelation of new possible players in modulation of Th17\/Treg differentiation and pathogenesis of multiple sclerosis. PLoS ONE 10:e0124555. https:\/\/doi.org\/10.1371\/journal.pone.0124555","journal-title":"PLoS ONE"},{"key":"13970_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2022.100510","volume":"25","author":"C Misrielal","year":"2022","unstructured":"Misrielal C, Alsema AM, Wijering MHC, Miedema A, Mauthe M, Reggiori F, Eggen BJL (2022) Transcriptomic changes in autophagy-related genes are inversely correlated with inflammation and are associated with multiple sclerosis lesion pathology. Brain Behav Immun Health 25:100510. https:\/\/doi.org\/10.1016\/j.bbih.2022.100510","journal-title":"Brain Behav Immun Health"},{"key":"13970_CR79","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.4049\/jimmunol.1601689","volume":"200","author":"F Zhang","year":"2018","unstructured":"Zhang F, Liu G, Li D, Wei C, Hao J (2018) DDIT4 and associated lncDDIT4 modulate Th17 differentiation through the DDIT4\/TSC\/mTOR pathway. J Immunol 200:1618\u20131626. https:\/\/doi.org\/10.4049\/jimmunol.1601689","journal-title":"J Immunol"},{"key":"13970_CR80","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nm.3411","volume":"20","author":"F Carbone","year":"2014","unstructured":"Carbone F, De Rosa V, Carrieri PB, Montella S, Bruzzese D, Porcellini A, Procaccini C, La Cava A, Matarese G (2014) Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat Med 20:69\u201374. https:\/\/doi.org\/10.1038\/nm.3411","journal-title":"Nat Med"},{"key":"13970_CR81","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/1735-5362.251851","volume":"14","author":"S Rezapour-Firouzi","year":"2019","unstructured":"Rezapour-Firouzi S, Kheradmand F, Shahabi S, Tehrani AA, Mazloomi E, Mohammadzadeh A (2019) Regulatory effects of hemp seed\/evening primrose oil supplement in comparison with rapamycin on the expression of the mammalian target of rapamycin-complex 2 and interleukin-10 genes in experimental autoimmune encephalomyelitis. Res Pharm Sci 14:36\u201345. https:\/\/doi.org\/10.4103\/1735-5362.251851","journal-title":"Res Pharm Sci"},{"key":"13970_CR82","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.3390\/cells9102218","volume":"9","author":"RM Wise","year":"2020","unstructured":"Wise RM, Harrison MAA, Sullivan BN, Al-Ghadban S, Aleman SJ, Vinluan AT, Monaco ER, Donato UM, Pursell IA, Bunnell BA (2020) Short-term Rapamycin preconditioning diminishes therapeutic efficacy of human adipose-derived stem cells in a Murine model of multiple sclerosis. Cells 9:2218. https:\/\/doi.org\/10.3390\/cells9102218","journal-title":"Cells"},{"key":"13970_CR83","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/imm.13870","volume":"174","author":"R Coulombeau","year":"2025","unstructured":"Coulombeau R, Selck C, Giang N, Al-Mohammad A, Ng N, Maher AK, Arg\u00fcello R, Scalfari A, Varley J, Nicholas R, Dominguez-Villar M (2025) Sphingosine-1-phosphate signalling inhibition suppresses Th1-like Treg generation by reversing mitochondrial uncoupling. Immunology 174:153\u2013166. https:\/\/doi.org\/10.1111\/imm.13870","journal-title":"Immunology"},{"key":"13970_CR84","doi-asserted-by":"publisher","first-page":"121","DOI":"10.15412\/J.BCN.03070206","volume":"7","author":"F Talaei","year":"2016","unstructured":"Talaei F (2016) Pathophysiological concepts in multiple sclerosis and the therapeutic effects of hydrogen sulfide, Basic Clin. Neurosci 7:121\u2013136. https:\/\/doi.org\/10.15412\/J.BCN.03070206","journal-title":"Neurosci"},{"key":"13970_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1068","volume":"12","author":"T Burkard","year":"2022","unstructured":"Burkard T, Herrero San Juan M, Dreis C, Kiprina A, Namgaladze D, Siebenbrodt K, Luger S, Foerch C, Pfeilschifter JM, Weigert A, Radeke HH (2022) Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis. Clin Transl Med 12:e1068. https:\/\/doi.org\/10.1002\/ctm2.1068","journal-title":"Clin Transl Med"},{"key":"13970_CR86","doi-asserted-by":"publisher","first-page":"8263","DOI":"10.18632\/oncotarget.23862","volume":"9","author":"S Mammana","year":"2018","unstructured":"Mammana S, Bramanti P, Mazzon E, Cavalli E, Basile MS, Fagone P, Petralia MC, McCubrey JA, Nicoletti F, Mangano K (2018) Preclinical evaluation of the PI3K\/Akt\/mTOR pathway in animal models of multiple sclerosis. Oncotarget 9:8263\u20138277. https:\/\/doi.org\/10.18632\/oncotarget.23862","journal-title":"Oncotarget"},{"key":"13970_CR87","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00401-019-02018-8","volume":"138","author":"R Hoepner","year":"2019","unstructured":"Hoepner R, Bagnoud M, Pistor M, Salmen A, Briner M, Synn H, Schrewe L, Guse K, Ahmadi F, Demir S, Laverick L, Gresle M, Worley P, Reichardt HM, Butzkueven H, Gold R, Metz I, L\u00fchder F, Chan A (2019) Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta Neuropathol 138:443\u2013456. https:\/\/doi.org\/10.1007\/s00401-019-02018-8","journal-title":"Acta Neuropathol"},{"key":"13970_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106387","volume":"191","author":"D Buonvicino","year":"2024","unstructured":"Buonvicino D, Pratesi S, Ranieri G, Pistolesi A, Guasti D, Chiarugi A (2024) The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis. Neurobiol Dis 191:106387. https:\/\/doi.org\/10.1016\/j.nbd.2023.106387","journal-title":"Neurobiol Dis"},{"key":"13970_CR89","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.msard.2018.08.009","volume":"26","author":"B Bagherpour","year":"2018","unstructured":"Bagherpour B, Salehi M, Jafari R, Bagheri A, Kiani-Esfahani A, Edalati M, Kardi MT, Shaygannejad V (2018) Promising effect of rapamycin on multiple sclerosis. Mult Scler Relat Disord 26:40\u201345. https:\/\/doi.org\/10.1016\/j.msard.2018.08.009","journal-title":"Mult Scler Relat Disord"},{"key":"13970_CR90","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41467-021-20892-3","volume":"12","author":"X Chamling","year":"2021","unstructured":"Chamling X, Kallman A, Fang W, Berlinicke CA, Mertz JL, Devkota P, Pantoja IEM, Smith MD, Ji Z, Chang C, Kaushik A, Chen L, Whartenby KA, Calabresi PA, Mao H-Q, Ji H, Wang T-H, Zack DJ (2021) Single-cell transcriptomic reveals molecular diversity and developmental heterogeneity of human stem cell-derived oligodendrocyte lineage cells. Nat Commun 12:652. https:\/\/doi.org\/10.1038\/s41467-021-20892-3","journal-title":"Nat Commun"},{"key":"13970_CR91","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/glia.22584","volume":"62","author":"ML De Paula","year":"2014","unstructured":"De Paula ML, Cui Q-L, Hossain S, Antel J, Almazan G (2014) The PTEN inhibitor bisperoxovanadium enhances myelination by amplifying IGF-1 signaling in rat and human oligodendrocyte progenitors. Glia 62:64\u201377. https:\/\/doi.org\/10.1002\/glia.22584","journal-title":"Glia"},{"key":"13970_CR92","doi-asserted-by":"publisher","first-page":"16676","DOI":"10.1038\/srep16676","volume":"5","author":"M Barbierato","year":"2015","unstructured":"Barbierato M, Facci L, Marinelli C, Zusso M, Argentini C, Skaper SD, Giusti P (2015) Co-ultramicronized palmitoylethanolamide\/luteolin promotes the maturation of oligodendrocyte precursor cells. Sci Rep 5:16676. https:\/\/doi.org\/10.1038\/srep16676","journal-title":"Sci Rep"},{"key":"13970_CR93","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12035-017-0722-0","volume":"55","author":"SD Skaper","year":"2018","unstructured":"Skaper SD, Barbierato M, Facci L, Borri M, Contarini G, Zusso M, Giusti P (2018) Co-ultramicronized palmitoylethanolamide\/luteolin facilitates the development of differentiating and undifferentiated rat oligodendrocyte progenitor cells. Mol Neurobiol 55:103\u2013114. https:\/\/doi.org\/10.1007\/s12035-017-0722-0","journal-title":"Mol Neurobiol"},{"key":"13970_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.698133","volume":"12","author":"L Facci","year":"2021","unstructured":"Facci L, Barbierato M, Fusco M, Giusti P, Zusso M (2021) Co-ultramicronized palmitoylethanolamide\/luteolin-induced oligodendrocyte precursor cell differentiation is associated with Tyro3 receptor upregulation. Front Pharmacol 12:698133. https:\/\/doi.org\/10.3389\/fphar.2021.698133","journal-title":"Front Pharmacol"},{"key":"13970_CR95","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac025","volume":"4","author":"K Benardais","year":"2022","unstructured":"Benardais K, Ornelas IM, Fauveau M, Brown TL, Finseth LT, Panic R, Deboux C, Macklin WB, Wood TL, Nait-Oumesmar B (2022) p70S6 kinase regulates oligodendrocyte differentiation and is active in remyelinating lesions. Brain Commun. 4:fcac025. https:\/\/doi.org\/10.1093\/braincomms\/fcac025","journal-title":"Brain Commun."},{"key":"13970_CR96","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1021\/acschembio.1c00461","volume":"16","author":"JL Sax","year":"2021","unstructured":"Sax JL, Hubler Z, Allimuthu D, Adams DJ (2021) Screening reveals sterol derivatives with pro-differentiation, pro-survival, or potent cytotoxic effects on oligodendrocyte progenitor cells. ACS Chem Biol 16:1288\u20131297. https:\/\/doi.org\/10.1021\/acschembio.1c00461","journal-title":"ACS Chem Biol"},{"key":"13970_CR97","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/glia.23559","volume":"67","author":"MA Preston","year":"2019","unstructured":"Preston MA, Finseth LT, Bourne JN, Macklin WB (2019) A novel myelin protein zero transgenic zebrafish designed for rapid readout of in vivo myelination. Glia 67:650\u2013667. https:\/\/doi.org\/10.1002\/glia.23559","journal-title":"Glia"},{"key":"13970_CR98","doi-asserted-by":"publisher","first-page":"175909141455195","DOI":"10.1177\/1759091414551955","volume":"6","author":"HH Sachs","year":"2014","unstructured":"Sachs HH, Bercury KK, Popescu DC, Narayanan SP, Macklin WB (2014) A new model of cuprizone-mediated demyelination\/remyelination. ASN Neuro 6:175909141455195. https:\/\/doi.org\/10.1177\/1759091414551955","journal-title":"ASN Neuro"},{"key":"13970_CR99","doi-asserted-by":"publisher","first-page":"7093844","DOI":"10.1155\/2021\/7093844","volume":"2021","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Li T, Dong X, Wang X, Zhang Z, Zhao C, Kang X, Zheng R, Li X (2021) Untargeted metabolomic profiling of cuprizone-induced demyelination in mouse corpus callosum by UPLC-Orbitrap\/MS reveals potential metabolic biomarkers of CNS demyelination disorders. Oxid Med Cell Longev 2021:7093844. https:\/\/doi.org\/10.1155\/2021\/7093844","journal-title":"Oxid Med Cell Longev"},{"key":"13970_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104630","volume":"134","author":"L Wang","year":"2020","unstructured":"Wang L, Yang H, Zang C, Dong Y, Shang J, Chen J, Wang Y, Liu H, Zhang Z, Xu H, Bao X, Zhang D (2020) CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis. Neurobiol Dis 134:104630. https:\/\/doi.org\/10.1016\/j.nbd.2019.104630","journal-title":"Neurobiol Dis"},{"key":"13970_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2021.101098","volume":"24","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhu J, Ma W, Zhang W, Xie Y, Chen X, Zhu J, Liu Y, Qin X, Lin Y (2021) The remyelination effect of DNA framework nucleic acids on demyelinating diseases. Appl Mater Today 24:101098. https:\/\/doi.org\/10.1016\/j.apmt.2021.101098","journal-title":"Appl Mater Today"},{"key":"13970_CR102","doi-asserted-by":"publisher","first-page":"8321","DOI":"10.1523\/JNEUROSCI.1377-20.2021","volume":"41","author":"MA Jeffries","year":"2021","unstructured":"Jeffries MA, McLane LE, Khandker L, Mather ML, Evangelou AV, Kantak D, Bourne JN, Macklin WB, Wood TL (2021) MTOR signaling regulates metabolic function in oligodendrocyte precursor cells and promotes efficient brain remyelination in the cuprizone model. J Neurosci 41:8321\u20138337. https:\/\/doi.org\/10.1523\/JNEUROSCI.1377-20.2021","journal-title":"J Neurosci"},{"key":"13970_CR103","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.expneurol.2016.06.033","volume":"283","author":"CB Bai","year":"2016","unstructured":"Bai CB, Sun S, Roholt A, Benson E, Edberg D, Medicetty S, Dutta R, Kidd G, Macklin WB, Trapp B (2016) A mouse model for testing remyelinating therapies. Exp Neurol 283:330\u2013340. https:\/\/doi.org\/10.1016\/j.expneurol.2016.06.033","journal-title":"Exp Neurol"},{"key":"13970_CR104","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s43440-019-00019-8","volume":"72","author":"N Sanadgol","year":"2020","unstructured":"Sanadgol N, Barati M, Houshmand F, Hassani S, Clarner T, Shahlaei M, Golab F (2020) Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK\/Nrf2\/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period. Pharmacol Rep 72:641\u2013658. https:\/\/doi.org\/10.1007\/s43440-019-00019-8","journal-title":"Pharmacol Rep"},{"key":"13970_CR105","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s10571-020-01014-x","volume":"42","author":"MS Paladini","year":"2022","unstructured":"Paladini MS, Marangon D, Rossetti AC, Guidi A, Coppolino GT, Negri C, Spero V, Abbracchio MP, Lecca D, Molteni R (2022) Prenatal stress impairs spinal cord oligodendrocyte maturation via BDNF signaling in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Cell Mol Neurobiol 42:1225\u20131240. https:\/\/doi.org\/10.1007\/s10571-020-01014-x","journal-title":"Cell Mol Neurobiol"},{"key":"13970_CR106","doi-asserted-by":"publisher","first-page":"14235","DOI":"10.1038\/srep14235","volume":"5","author":"J-J Sun","year":"2015","unstructured":"Sun J-J, Ren Q-G, Xu L, Zhang Z-J (2015) LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice. Sci Rep 5:14235. https:\/\/doi.org\/10.1038\/srep14235","journal-title":"Sci Rep"},{"key":"13970_CR107","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae414","author":"JQA Chen","year":"2024","unstructured":"Chen JQA, McNamara NB, Engelenburg HJ, Jongejan A, Wever DD, Hopman K, van Rixel E, Nijhuis PJH, de Winter F, Moerland PD, Smolders J, Verhaagen J, Hamann J, Huitinga I (2024) Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis. Brain. https:\/\/doi.org\/10.1093\/brain\/awae414","journal-title":"Brain"},{"key":"13970_CR108","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1073\/pnas.1818348116","volume":"116","author":"AM Nicaise","year":"2019","unstructured":"Nicaise AM, Wagstaff LJ, Willis CM, Paisie C, Chandok H, Robson P, Fossati V, Williams A, Crocker SJ (2019) Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis. Proc Natl Acad Sci USA 116:9030\u20139039. https:\/\/doi.org\/10.1073\/pnas.1818348116","journal-title":"Proc Natl Acad Sci USA"},{"key":"13970_CR109","doi-asserted-by":"publisher","first-page":"95","DOI":"10.17305\/bjbms.2017.1696","volume":"17","author":"X Feng","year":"2017","unstructured":"Feng X, Hou H, Zou Y, Guo L (2017) Defective autophagy is associated with neuronal injury in a mouse model of multiple sclerosis. Bosn J Basic Med Sci 17:95\u2013103. https:\/\/doi.org\/10.17305\/bjbms.2017.1696","journal-title":"Bosn J Basic Med Sci"},{"key":"13970_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713225","author":"S Ceccariglia","year":"2023","unstructured":"Ceccariglia S, Sibilia D, Parolini O, Michetti F, Di Sante G (2023) Altered expression of autophagy biomarkers in hippocampal neurons in a multiple Sclerosis animal model. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241713225","journal-title":"Int J Mol Sci"},{"key":"13970_CR111","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/biology8020037","volume":"8","author":"IP de Barcelos","year":"2019","unstructured":"de Barcelos IP, Troxell RM, Graves JS (2019) Mitochondrial Dysfunction and Multiple Sclerosis. Biology 8:37. https:\/\/doi.org\/10.3390\/biology8020037","journal-title":"Biology"},{"key":"13970_CR112","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.trsl.2015.01.006","volume":"166","author":"D Hansen","year":"2015","unstructured":"Hansen D, Wens I, Vandenabeele F, Verboven K, Eijnde BO (2015) Altered signaling for mitochondrial and myofibrillar biogenesis in skeletal muscles of patients with multiple sclerosis. Transl Res 166:70\u201379. https:\/\/doi.org\/10.1016\/j.trsl.2015.01.006","journal-title":"Transl Res"},{"key":"13970_CR113","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jneuroim.2006.11.015","volume":"184","author":"LK Peterson","year":"2007","unstructured":"Peterson LK, Fujinami RS (2007) Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol 184:37\u201344. https:\/\/doi.org\/10.1016\/j.jneuroim.2006.11.015","journal-title":"J Neuroimmunol"},{"key":"13970_CR114","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.4049\/jimmunol.1701321","volume":"200","author":"AL Raybuck","year":"2018","unstructured":"Raybuck AL, Cho SH, Li J, Rogers MC, Lee K, Williams CL, Shlomchik M, Thomas JW, Chen J, Williams JV, Boothby MR (2018) B cell\u2013intrinsic mTORC1 promotes germinal center\u2013defining transcription factor gene expression, somatic hypermutation, and memory B cell generation in humoral immunity. J Immunol 200:2627\u20132639. https:\/\/doi.org\/10.4049\/jimmunol.1701321","journal-title":"J Immunol"},{"key":"13970_CR115","doi-asserted-by":"publisher","first-page":"1004795","DOI":"10.3389\/fimmu.2023.1004795","volume":"14","author":"J de S\u00e8ze","year":"2023","unstructured":"de S\u00e8ze J, Maillart E, Gueguen A, Laplaud DA, Michel L, Thouvenot E, Zephir H, Zimmer L, Biotti D, Liblau R (2023) Anti-CD20 therapies in multiple sclerosis: from pathology to the clinic. Front Immunol 14:1004795. https:\/\/doi.org\/10.3389\/fimmu.2023.1004795","journal-title":"Front Immunol"},{"key":"13970_CR116","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1756285612474333","volume":"6","author":"K Lehmann-Horn","year":"2013","unstructured":"Lehmann-Horn K, Kronsbein HC, Weber MS (2013) Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges. Ther Adv Neurol Disord 6:161\u2013173. https:\/\/doi.org\/10.1177\/1756285612474333","journal-title":"Ther Adv Neurol Disord"},{"key":"13970_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114769","volume":"452","author":"L Naserpour","year":"2025","unstructured":"Naserpour L, Jalise SZ, Khoshandam M, Hosseinzadeh F (2025) Molecular mechanism and the main signaling pathways in the development and progression of multiple sclerosis. Exp Cell Res 452:114769. https:\/\/doi.org\/10.1016\/j.yexcr.2025.114769","journal-title":"Exp Cell Res"},{"key":"13970_CR118","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1016\/j.celrep.2018.04.044","volume":"23","author":"T Karonitsch","year":"2018","unstructured":"Karonitsch T, Kandasamy RK, Kartnig F, Herdy B, Dalwigk K, Niederreiter B, Holinka J, Sevelda F, Windhager R, Bilban M, Weichhart T, S\u00e4emann M, Pap T, Steiner G, Smolen JS, Kiener HP, Superti-Furga G (2018) MTOR senses environmental cues to shape the fibroblast-like synoviocyte response to inflammation. Cell Rep 23:2157\u20132167. https:\/\/doi.org\/10.1016\/j.celrep.2018.04.044","journal-title":"Cell Rep"},{"key":"13970_CR119","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.neo.2019.05.002","volume":"21","author":"ES Hibdon","year":"2019","unstructured":"Hibdon ES, Razumilava N, Keeley TM, Wong G, Solanki S, Shah YM, Samuelson LC (2019) Notch and mTOR signaling pathways promote human gastric cancer cell proliferation. Neoplasia 21:702\u2013712. https:\/\/doi.org\/10.1016\/j.neo.2019.05.002","journal-title":"Neoplasia"},{"key":"13970_CR120","doi-asserted-by":"publisher","first-page":"1207007","DOI":"10.3389\/fnmol.2023.1207007","volume":"16","author":"D Packer","year":"2023","unstructured":"Packer D, Fresenko EE, Harrington EP (2023) Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration. Front Mol Neurosci 16:1207007. https:\/\/doi.org\/10.3389\/fnmol.2023.1207007","journal-title":"Front Mol Neurosci"},{"key":"13970_CR121","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1177\/1352458510379612","volume":"16","author":"HM Vesterinen","year":"2010","unstructured":"Vesterinen HM, Sena ES, Ffrench-Constant C, Williams A, Chandran S, Macleod MR (2010) Improving the translational hit of experimental treatments in multiple sclerosis. Mult Scler 16:1044\u20131055. https:\/\/doi.org\/10.1177\/1352458510379612","journal-title":"Mult Scler"},{"key":"13970_CR122","doi-asserted-by":"publisher","first-page":"175909141772517","DOI":"10.1177\/1759091417725174","volume":"9","author":"W Zhen","year":"2017","unstructured":"Zhen W, Liu A, Lu J, Zhang W, Tattersall D, Wang J (2017) An alternative cuprizone-induced demyelination and remyelination mouse model. ASN Neuro 9:1759091417725174. https:\/\/doi.org\/10.1177\/1759091417725174","journal-title":"ASN Neuro"},{"key":"13970_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911532","volume":"23","author":"D Birmpili","year":"2022","unstructured":"Birmpili D, Charmarke Askar I, Bigaut K, Bagnard D (2022) The translatability of multiple Sclerosis animal models for biomarkers discovery and their clinical use. Int J Mol Sci 23:11532. https:\/\/doi.org\/10.3390\/ijms231911532","journal-title":"Int J Mol Sci"},{"key":"13970_CR124","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/ijnp\/pyz027","volume":"22","author":"P O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell P, Rosen L, Alexander R, Murthy V, Davies CH, Ratti E (2019) Strategies to address challenges in neuroscience drug discovery and development. Int J Neuropsychopharmacol 22:445\u2013448. https:\/\/doi.org\/10.1093\/ijnp\/pyz027","journal-title":"Int J Neuropsychopharmacol"},{"key":"13970_CR125","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.29241","volume":"6","author":"G Figlia","year":"2017","unstructured":"Figlia G, Norrm\u00e9n C, Pereira JA, Gerber D, Suter U (2017) Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system. Elife 6:e29241. https:\/\/doi.org\/10.7554\/eLife.29241","journal-title":"Elife"},{"key":"13970_CR126","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.celrep.2014.09.001","volume":"9","author":"C Norrm\u00e9n","year":"2014","unstructured":"Norrm\u00e9n C, Figlia G, Lebrun-Julien F, Pereira JA, Tr\u00f6tzm\u00fcller M, K\u00f6feler HC, Rantanen V, Wessig C, van Deijk A-LF, Smit AB, Verheijen MHG, R\u00fcegg MA, Hall MN, Suter U (2014) mTORC1 controls PNS myelination along the mTORC1-RXR\u03b3-SREBP-lipid biosynthesis axis in Schwann cells. Cell Rep 9:646\u2013660. https:\/\/doi.org\/10.1016\/j.celrep.2014.09.001","journal-title":"Cell Rep"},{"key":"13970_CR127","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/glia.23273","volume":"66","author":"G Figlia","year":"2018","unstructured":"Figlia G, Gerber D, Suter U (2018) Myelination and mTOR. Glia 66:693\u2013707. https:\/\/doi.org\/10.1002\/glia.23273","journal-title":"Glia"},{"key":"13970_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020455","author":"B Medici","year":"2025","unstructured":"Medici B, Caffari E, Maculan Y, Benatti S, Piacentini F, Dominici M, Gelsomino F (2025) Everolimus in the treatment of neuroendocrine tumors: Lights and shadows. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13020455","journal-title":"Biomedicines"},{"key":"13970_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-04043-8","author":"D Hurtado-Sierra","year":"2025","unstructured":"Hurtado-Sierra D, Ramos Garz\u00f3n JX, Romero-Guevara SL, Serrano-Garc\u00eda AY, Rojas LZ (2025) Everolimus and sirolimus in the treatment of cardiac rhabdomyomas in neonates. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-025-04043-8","journal-title":"Pediatr Res"},{"key":"13970_CR130","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1016\/S2666-7568(23)00258-1","volume":"5","author":"DJW Lee","year":"2024","unstructured":"Lee DJW, Hodzic Kuerec A, Maier AB (2024) Targeting ageing with rapamycin and its derivatives in humans: a systematic review. Lancet Healthy Longev. 5:e152\u2013e162. https:\/\/doi.org\/10.1016\/S2666-7568(23)00258-1","journal-title":"Lancet Healthy Longev."},{"key":"13970_CR131","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-01911-3","author":"HA Wallgren","year":"2025","unstructured":"Wallgren HA, Kivipelto M, Plav\u00e9n-Sigray P, Svensson JE (2025) Pharmacokinetic analysis of intermittent rapamycin administration in early-stage Alzheimer\u2019s Disease. GeroScience. https:\/\/doi.org\/10.1007\/s11357-025-01911-3","journal-title":"GeroScience"},{"key":"13970_CR132","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s43856-025-00904-9","volume":"5","author":"MM Gonzales","year":"2025","unstructured":"Gonzales MM, Garbarino VR, Kautz TF, Song X, Lopez-Cruzan M, Linehan L, Van Skike CE, De Erausquin GA, Galvan V, Orr ME, Musi N, He Y, Bateman RJ, Wang C-P, Seshadri S, Kraig E, Kellogg D Jr (2025) Rapamycin treatment for Alzheimer\u2019s disease and related dementias: a pilot phase 1 clinical trial. Commun Med (Lond) 5:189. https:\/\/doi.org\/10.1038\/s43856-025-00904-9","journal-title":"Commun Med (Lond)"},{"key":"13970_CR133","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, Sengupta S, Kumar D, Garg M (2023) Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther 8:375. https:\/\/doi.org\/10.1038\/s41392-023-01608-z","journal-title":"Signal Transduct Target Ther"},{"key":"13970_CR134","doi-asserted-by":"publisher","first-page":"545","DOI":"10.12998\/wjcc.v3.i7.545","volume":"3","author":"A Gajofatto","year":"2015","unstructured":"Gajofatto A, Benedetti MD (2015) Treatment strategies for multiple sclerosis When to start, when to change, when to stop?, World. J Clin Cases 3:545\u2013555. https:\/\/doi.org\/10.12998\/wjcc.v3.i7.545","journal-title":"J Clin Cases"},{"key":"13970_CR135","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s10571-017-0472-6","volume":"37","author":"M Motavaf","year":"2017","unstructured":"Motavaf M, Sadeghizadeh M, Javan M (2017) Attempts to overcome remyelination failure: Toward opening new therapeutic avenues for multiple sclerosis. Cell Mol Neurobiol 37:1335\u20131348. https:\/\/doi.org\/10.1007\/s10571-017-0472-6","journal-title":"Cell Mol Neurobiol"},{"key":"13970_CR136","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41392-025-02415-4","volume":"10","author":"I Boutitah-Benyaich","year":"2025","unstructured":"Boutitah-Benyaich I, Eixarch H, Villacieros-\u00c1lvarez J, Hervera A, Cobo-Calvo \u00c1, Montalban X, Espejo C (2025) Multiple sclerosis: molecular pathogenesis and therapeutic intervention. Signal Transduct Target Ther 10:324. https:\/\/doi.org\/10.1038\/s41392-025-02415-4","journal-title":"Signal Transduct Target Ther"},{"key":"13970_CR137","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s40265-025-02212-x","volume":"85","author":"L Zuroff","year":"2025","unstructured":"Zuroff L, Farkhondeh V, Bove R, Green AJ (2025) The road to remyelination in multiple sclerosis: Breakthroughs, challenges, and considerations for future trial design. Drugs 85:1337\u20131362. https:\/\/doi.org\/10.1007\/s40265-025-02212-x","journal-title":"Drugs"},{"key":"13970_CR138","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3934\/Neuroscience.2025027","volume":"12","author":"GK Garcha","year":"2025","unstructured":"Garcha GK, Ahmed M (2025) Remyelination as a therapeutic target in the treatment of multiple sclerosis. AIMS Neurosci 12:539\u2013569. https:\/\/doi.org\/10.3934\/Neuroscience.2025027","journal-title":"AIMS Neurosci"},{"key":"13970_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101009","volume":"44","author":"M Di Filippo","year":"2024","unstructured":"Di Filippo M, Gaetani L, Centonze D, Hegen H, Kuhle J, Teunissen CE, Tintor\u00e9 M, Villar LM, Willemse EAJ, Zetterberg H, Parnetti L (2024) Fluid biomarkers in multiple sclerosis: from current to future applications. Lancet Reg Health Eur 44:101009. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101009","journal-title":"Lancet Reg Health Eur"},{"key":"13970_CR140","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","volume":"22","author":"ES Ali","year":"2022","unstructured":"Ali ES, Mitra K, Akter S, Ramproshad S, Mondal B, Khan IN, Islam MT, Sharifi-Rad J, Calina D, Cho WC (2022) Recent advances and limitations of mTOR inhibitors in the treatment of cancer. Cancer Cell Int 22:284. https:\/\/doi.org\/10.1186\/s12935-022-02706-8","journal-title":"Cancer Cell Int"},{"key":"13970_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101504","volume":"33","author":"PJH Nijhuis","year":"2025","unstructured":"Nijhuis PJH, Romijn M, Honing R, van Zon G, Huitinga I, de Winter F, Verhaagen J (2025) Developing a minimally invasive gene therapy for multiple sclerosis. Mol Ther Methods Clin Dev 33:101504. https:\/\/doi.org\/10.1016\/j.omtm.2025.101504","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13970-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13970-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13970-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:49:31Z","timestamp":1786348171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13970-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":141,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["13970"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13970-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"441"}}